These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
384 related items for PubMed ID: 27784014
1. Early Prediction of the Outcome Using Tumor Markers and mRECIST in Unresectable Hepatocellular Carcinoma Patients Who Underwent Transarterial Chemoembolization. Ichikawa T, Machida N, Sasaki H, Tenmoku A, Kaneko H, Negishi R, Oi I, Fujino MA. Oncology; 2016; 91(6):317-330. PubMed ID: 27784014 [Abstract] [Full Text] [Related]
3. Evaluation of Tumor Response Using Alpha-fetoprotein and Des-gamma-carboxy Prothrombin in Hepatocellular Carcinoma Patients Who Underwent Transarterial Chemoembolization. Cerban R, Ester C, Iacob S, Paslaru L, Dumitru R, Grasu M, Constantin G, Popescu I, Gheorghe L. Chirurgia (Bucur); 2018; 113(4):524-533. PubMed ID: 30183583 [Abstract] [Full Text] [Related]
6. Comparison of α-Fetoprotein Criteria and Modified Response Evaluation Criteria in Solid Tumors for the Prediction of Overall Survival of Patients with Hepatocellular Carcinoma after Transarterial Chemoembolization. Zhang YQ, Jiang LJ, Wen J, Liu DM, Huang GH, Wang Y, Fan WZ, Li JP. J Vasc Interv Radiol; 2018 Dec; 29(12):1654-1661. PubMed ID: 30396842 [Abstract] [Full Text] [Related]
7. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization. Green TJ, Rochon PJ, Chang S, Ray CE, Winston H, Ruef R, Kreidler SM, Glueck DH, Shulman BC, Brown AC, Durham J. J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436 [Abstract] [Full Text] [Related]
12. Evaluation of the mRECIST and α-fetoprotein ratio for stratification of the prognosis of advanced-hepatocellular-carcinoma patients treated with sorafenib. Kawaoka T, Aikata H, Murakami E, Nakahara T, Naeshiro N, Tanaka M, Honda Y, Miyaki D, Nagaoki Y, Takaki S, Hiramatsu A, Waki K, Takahashi S, Chayama K. Oncology; 2012 Nov; 83(4):192-200. PubMed ID: 22890083 [Abstract] [Full Text] [Related]
18. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis. Shimizu A, Shiraki K, Ito T, Sugimoto K, Sakai T, Ohmori S, Murata K, Takase K, Tameda Y, Nakano T. Int J Mol Med; 2002 Mar; 9(3):245-50. PubMed ID: 11836630 [Abstract] [Full Text] [Related]
19. Prospective comparison of prognostic values of modified Response Evaluation Criteria in Solid Tumours with European Association for the Study of the Liver criteria in hepatocellular carcinoma following chemoembolisation. Kim BK, Kim KA, Park JY, Ahn SH, Chon CY, Han KH, Kim SU, Kim MJ. Eur J Cancer; 2013 Mar; 49(4):826-34. PubMed ID: 22995582 [Abstract] [Full Text] [Related]
20. Hepatic resection after transarterial chemoembolization increases overall survival in large/multifocal hepatocellular carcinoma: a retrospective cohort study. Chen J, Lai L, Lin Q, Huang W, Cai M, Zhu K, Huang M. Oncotarget; 2017 Jan 03; 8(1):408-417. PubMed ID: 27880724 [Abstract] [Full Text] [Related] Page: [Next] [New Search]